Eudaimonia Partners, LLC Novo Nordisk A S Transaction History

Eudaimonia Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $31,461 - $39,413	-465 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $11,735 - $13,268	175 Added 60.34%	465 $31,000
Q4 2020 Feb 18, 2021	SELL	$63.89 - $73.8 $5,622 - $6,494	-88 Reduced 23.28%	290 $20,000
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $13,374 - $14,746	-210 Reduced 35.71%	378 $26,000
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $32,021 - $37,163	-547 Reduced 48.19%	588 $39,000
Q1 2020 May 05, 2020	BUY	$49.46 - $64.78 $31,407 - $41,135	635 Added 127.0%	1,135 $68,000
Q4 2019 May 05, 2020	BUY	$49.86 - $58.26 $24,930 - $29,130	500 New	500 $29,000

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.